Markers of a hypercoagulable state following acute ischemic stroke.

BACKGROUND AND PURPOSE The nature of hematologic disorders in different stroke subtypes remains uncertain. The purpose of this study was to clarify the differences in the coagulation and fibrinolytic activities among ischemic stroke subtypes. METHODS We performed sequential measurements of hematologic parameters in 21 patients with acute cardioembolic stroke, 10 patients with atherothrombotic stroke, 23 patients with lacunar stroke, and 20 age-matched controls. RESULTS A marked elevation of plasma concentrations of the thrombin-antithrombin III complex and crosslinked D-dimer was observed only in cardioembolic stroke within 48 hours of onset (p less than 0.01), persisting for one month with a gradual decline. In atherothrombotic stroke, however, the level of crosslinked D-dimer was not elevated at the onset, but increased seven days after onset (p less than 0.01). No significant changes in these marker levels were observed in lacunar stroke. CONCLUSIONS Our findings suggest that the nature of altered coagulation and fibrinolysis are different in various subtypes of ischemic stroke, and that an assessment of these hematologic parameters may be useful for the early classification of these subtypes.

[1]  T. Omae,et al.  Activation of coagulation in acute cardioembolic stroke. , 1991, Stroke.

[2]  M. Fisher,et al.  Altered coagulation in cerebral ischemia. Platelet, thrombin, and plasmin activity. , 1990, Archives of neurology.

[3]  W. Kisiel,et al.  Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. , 1990, Thrombosis research.

[4]  W. Feinberg,et al.  Hemostatic markers in acute stroke. , 1989, Stroke.

[5]  P. Mannucci,et al.  Protein C in acute stroke. , 1988, Stroke.

[6]  A. Morabito,et al.  Hypercoagulability in acute stroke , 1987, Neurology.

[7]  H. Pelzer,et al.  Enzyme immunoassay for determination of human thrombin/antithrombin III complex , 1986 .

[8]  D. Rylatt,et al.  An immunoassay for human D dimer using monoclonal antibodies. , 1983, Thrombosis research.

[9]  M. Gaweł,et al.  Activation of coagulation and fibrinolytic systems following stroke , 1983, British journal of haematology.

[10]  B. Bennett,et al.  Familial antithrombin III deficiency. , 1982, The Quarterly journal of medicine.

[11]  C. Fisher Lacunar strokes and infarcts , 1982, Neurology.

[12]  K. Mettinger A study of hemostasis in ischemic cerebrovascular disease. I. Abnormalities in factor VIII and antithrombin. , 1982, Thrombosis research.

[13]  A. Turpie,et al.  Plasma betathromboglobulin and serum fragment E in acute partial stroke , 1982, British journal of haematology.

[14]  O. Odegård,et al.  Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). , 1977, Thrombosis research.

[15]  E. Henningsson,et al.  Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex. , 1977, Journal of immunological methods.

[16]  M. Tsapogas,et al.  Altered endogenous fibrinolysis and biochemical factors in atherosclerosis. , 1974, Archives of surgery.

[17]  J. Fahey,et al.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. , 1965, Journal of immunology.